Haemodynamic responses and population pharmacokinetics of midazolam following administration to ventilated, preterm neonates

Journal of Paediatrics and Child Health

Volumn 33, Issue 4, 1997, Pages 335-338

  Harte, G J ^a   Gray, P H ^a   Lee, T C ^b   Steer, P A ^a   Charles, B G ^b  

^a MATER MOTHERS HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cerebral blood flow velocity; Midazolam; Pharmacokinetics

Indexed keywords

MIDAZOLAM;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN BLOOD FLOW; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; HEMODYNAMICS; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; NEWBORN INTENSIVE CARE; PEDIATRIC ANESTHESIA; PREMATURITY; PRIORITY JOURNAL; SEDATION; VERY LOW BIRTH WEIGHT;

EID: 0030783008     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb01611.x     Document Type: Article

References (30)

1. Anand KJ, Hickey PR. Pain and its effect in the human foetus. N. Engl. J. Med. 1987; 9: 1321-9.
2. Levene MI, Quinn MW. Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation. Arch. Dis. Child. 1992; 67: 870-3.
3. Greenough A, Morley CJ, Wood S, Davis JA. Pancuronium prevents pneumothoraces in ventilated premature babies who actively expire against positive pressure ventilation. Lancet 1984; i: 1-3.
4. Burtin P, Daoud P, Jacqz-Aigrain E, Mussat P, Moriette G. Hypotension with midazolam and fentanyl in the newborn. Lancet 1991; 337: 1545-6.
5. Jacqz-Aigrain E, Daoud P, Burtin P, Maherzi S, Beaufils F. Pharmacokinetics of midazolam during continuous infusion in critically ill neonates. Eur. J. Clin. Pharmacol. 1992; 42: 329-2.
6. van den Ander JN, Sauer PJ. The use of midazolam in the preterm neonate. Eur. J. Pediatr. 1992; 151: 152.
7. van Straaten HLM, Rademaker CMA, de Vries LS. Comparison of the effect of midazolam or vecuronium on blood pressure and cerebral blood flow velocity in the premature newborn. Dev. Pharmacol. Ther. 1992; 19: 191-5.
8. Magny JF, d'Allest AM, Nedelcoux H et al. Midazolam and myoclonus in neonate. Eur. J. Pediatr. 1994; 153: 389-92.
9. Jacqz-Aigrain E, Wood C, Robiex I. Pharmocokinetics of midazolam in critically ill neonates. Eur. J. Clin. Pharmacol. 1990; 39: 191-2.
10. Toila V, Brennan S, Aravino MK, Kauffman RE. Pharmacokinetic and pharmacodynamic study of midazolam in children with esophagogastro-duodenoscopy. J. Pediatr. 1991; 119: 467-71.
11. 2 on cerebral blood flow velocity in preterm infants of less than 33 weeks' gestation. Pediatr. Res. 1993; 34: 173-7.
12. Lee TC, Charles BG. Measurement by HPLC of midazolam and its major metabolite, 1-hydroxymidazolam in plasma of very premature neonates. Biomed. Chromatog. 1995; 10: 65-8.
13. Boekmann AJ, Sheiner LB, Beal SL. NONMEM User's Guide. University of California, San Francisco. NONMEM Project Group, 1992.
14. Bode H, Wais U. Age dependence of flow velocities in basal cerebral arteries. Arch. Dis. Child. 1988; 63: 606-11.
15. Forster A, Juge O, Morel D. Effects of midazolam on cerebral blood flow in human volunteers. Anesthesiology 1982; 56: 453-5.
16. Gray PH, Griffin EA, Drumm JE, Fitzgerald DE, Duignan NM. Continuous Doppler ultrasound in evaluation of cerebral blood flow in neonates. Arch. Dis. Child. 1983; 58: 677-81.
17. Evans DH, Levene MI, Archer LN. The effect of indomethacin on cerebral blood flow velocity in premature infants. Dev. Med. Child. Neurol. 1987; 29: 776-82.
18. Chang J, Gray PH. Aminophylline therapy and cerebral blood flow velocity in preterm infants. J. Pediatr. Child Health 1994; 30: 123-5.
19. Cowan F, Whitelaw A, Wertheim D, Silverman M. Cerebral blood flow velocity changes after rapid administration of surfactant. Arch. Dis. Child. 1991; 66: 1105-9.
20. Fleischer JE, Milde JH, Moyer TP, Michenfelder JD. Cerebral effects of high-dose midazolam and subsequent reversal with Ro 15-1788 in dogs. Anesthesiology 1988; 68: 234-42.
21. Björkman S, Åkeson J, Nilsson F, Messeter K, Roth B. Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: An application of mass balance pharmacokinetics with a changing regional blood flow. J. Pharmaco. Biopharm. 1992; 20: 637-52.
22. Knudsen L, Cold GE, Holgard HO, Johansen UT, Jensen S. The effects of midazolam on cerebral blood flow and oxygen consumption. Anaesthesia 1990; 45: 1016-9.
23. Greisen G. Ischaemia of the preterm brain. Biol. Neon. 1992; 62: 243-7.
24. Fenton AC, Woods KL, Evans DH, Levene MI. Cerebrovascular carbon dioxide reactivity and failure or autoregulation in preterm infants. Arch. Dis. Child. 1992; 67: 835-9.
25. Pryds O, Greisen G, Lou H, Friis-Hansen B. Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilation. J. Pediatr. 1989; 115: 638-45.
26. Hartwig S, Roth B, Theisohn M. Clinical experience with continuous intravenous sedation using midazolam and fentanyl in the paediatric intensive care unit. Eur. J. Pediatr. 1991; 150: 784-8.
27. Jacqz-Aigrain E, Daoud P, Burton P, Desplanques L, Beaufils F. Placebo-controlled trial of midazolam sedation in mechanically ventilated newborn babies. Lancet 1994; 344: 646-50.
28. Payne K, Mattheyse FJ, Lienbenberg D, Dawes T. The pharmacokinetics of midazolam in paediatric patients. Eur. J. Clin. Pharmacol. 1989; 37: 267-72.
29. Maitre PO, Funk B, Crevoisier C, Ha HR. Pharmacokinetics of midazolam in patients recovering from cardiac surgery. Eur. J. Clin. Pharmacol. 1989; 37: 161-6.
30. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin. Pharmacol. Ther. 1981; 30: 653-61.